Lantheus Holdings (NasdaqGM:LNTH) saw an 18.83% increase in its share price over the past week, driven by recent corporate updates and market trends. The company announced its 2024 earnings, reporting ...
William Blair analyst Andy Hsieh maintained a Hold rating on Lantheus (LNTH – Research Report) today. The company’s shares closed today at ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Certara (CERT – Research Report), Lantheus ...
Following the Food and Drug Administration’s approval of Lutathera and Pluvicto in 2018 and 2022, respectively, we predicted ...
Since the existence of the oligometastatic disease state was posited three decades ago,1 there has been interest in ...
As February 2025 comes to a close, the U.S. stock market has experienced a mixed performance with major indexes posting losses for the month despite a late surge fueled by easing inflation concerns.
Global Radiopharmaceuticals Market is valued at USD 5.2 Billion in 2022.Global Radiopharmaceuticals Market valuation to reach ...